Affymetrix Transfers Ownership of CLIA Lab to Navigenics

Affy has decided to refocus its efforts on its core microarray platform and being an enabler for the broad adoption of microarrays across all genetic analysis markets, including CLIA lab services. Meanwhile, Navigenics takes over ownership of the lab as the volume of orders for its genetic screening service has increased.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.